Trial Profile
Multicenter, Double-Blind, Placebo-Controlled, Two-Arm, Randomized, Parallel, Treatment Intervention, Sleep Lab Phase 4 Study to Assess the Effect of Rotigotine on Nocturnal Blood Pressure in Patients With Idiopathic Restless Legs Syndrome.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Jun 2016
Price :
$35
*
At a glance
- Drugs Rotigotine (Primary)
- Indications Restless legs syndrome
- Focus Pharmacodynamics
- Acronyms ENCORE
- Sponsors UCB
- 10 May 2016 Results published in the Neurology
- 03 May 2014 Results presented at the 66th Annual Meeting of the American Academy of Neurology.
- 31 Mar 2014 Results presented at the 63rd Annual Scientific Session of the American College of Cardiology.